लोड हो रहा है...
Inhaled Tobramycin Effectively Reduces FEV(1) Decline in Cystic Fibrosis. An Instrumental Variables Analysis
Rationale: The efficacy of inhaled tobramycin on chronic Pseudomonas aeruginosa infections in patients with cystic fibrosis (CF) has been established in clinical trials. However, little is known about its clinical effectiveness on lung function outside randomized controlled trial settings; conventio...
में बचाया:
| में प्रकाशित: | Ann Am Thorac Soc |
|---|---|
| मुख्य लेखकों: | , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
American Thoracic Society
2013
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5475429/ https://ncbi.nlm.nih.gov/pubmed/23802816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1513/AnnalsATS.201209-082OC |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|